Return to Article Details
TARGETING TYPE I INTERFERON SIGNALING IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL AND SAFETY PERSPECTIVES ON ANIFROLUMAB THERAPY
Download
Download PDF